What Is Cutaneous Lymphoma?

Cutaneous lymphomas comprise a rare group of Non-Hodgkins lymphoma that arise primarily in the skin. The Stanford Cutaneous Lymphoma Program is expert in the treatment and investigation of all forms of cutaneous lymphoma, including the relatively more common T-cell and B-cell cutaneous lymphomas.

Stanford Cutaneous Lymphoma Program

The Stanford multispecialty Cutaneous Lymphoma team offers expert treatment for patients with cutaneous lymphomas, including mycosis fungoides, Sezary syndrome, CD30+ lymphoproliferative disorders (lymphomatoid papulosis and anaplastic large cell lymphoma), subcutaneous panniculitis-like T-cell lymphoma, gamma-delta T-cell lymphoma, CD8+ aggressive epidermotropic T-cell lymphoma, NK/T-cell lymphoma, other unspecified cutaneous peripheral T-cell lymphomas, and cutaneous B-cell lymphomas. Our physicians subspecialize in treating these types of cancers, and have extensive expertise in handling the most complicated cases. Care among specialists is tightly integrated.

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Before beginning treatment, ask your doctor about any clinical trials you should consider. Learn more about clinical trials for cancer patients.

Clinical trial eligibility flowcharts

Eligibility flowcharts map clinical trials to specific types of cancers to determine if a participant is eligible for the particular clinical trial. View all lymphoma eligibility flowcharts at the Stanford Cancer Institute.

Our Clinics

See a Stanford specialist to learn about your treatment options. Visit our clinics to make an appointment.